Sector Update: Health Care Stocks Decline Late Afternoon

MT Newswires Live12-02

Health care stocks dropped late Monday afternoon with the NYSE Health Care Index decreasing 1.1% and the Health Care Select Sector SPDR Fund (XLV) falling 1.3%.

The iShares Biotechnology ETF (IBB) dropped 2.1%.

In corporate news, Omeros (OMER) closed the asset sale and licensing deal with Novo Nordisk (NVO) for Omeros' candidate drug zaltenibart. Novo shares fell 1.7%, and Omeros shed 0.8%.

UnitedHealth (UNH) agreed to sell its South American business Banmedica to private equity firm Patria Investments for $1 billion, Reuters reported Sunday. UnitedHealth shares fell 1.4%.

Merck (MRK) said its investigational therapy MK-2214 was granted fast-track designation by the US Food and Drug Administration for the treatment of Alzheimer's disease. Merck shares fell 2.6%.

Bausch Health (BHC) shares jumped 11% after the company said its aesthetic business, Solta Medical, completed the acquisition of Wuhan Shibo Zhenmei Technology, its long-time distribution partner in China.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment